Business Context and Reporting Period
Company: Viewbix Inc. (Note: Metadata referenced "Quantum X Labs Inc." but the filing identifies Viewbix Inc. as the registrant acquiring Quantum X Labs Ltd.)
Reporting Date: December 15, 2025
Event: Entry into a Material Definitive Agreement (Securities Exchange Agreement) to acquire Quantum X Labs Ltd. ("Quantum").
Key Financial Metrics and Transaction Structure
This filing describes a proposed acquisition rather than reporting standard financial performance metrics (revenue, profit, cash flow). The filing text does not provide clear values for Viewbix's current revenue, profit, or debt levels.
| Transaction Component | Details |
|---|---|
| Consideration | Up to 40.0% of Viewbix's issued and outstanding capital stock. |
| Viewbix Exchange Shares | Up to 2,666,000 shares (approx. 19.99% of outstanding stock). |
| Pre-Funded Warrants | Warrants to purchase up to 4,447,595 shares (exercise price $0.0001). |
| Target Acquisition | Up to 100% (not less than 85%) of Quantum's share capital (up to 589,319 ordinary shares). |
| Private Placement | Includes 800,000 shares previously agreed upon in a Nov 5, 2025 agreement. |
Material Changes and Earn-Out Provisions
The transaction represents a material change in corporate structure, with Quantum becoming a subsidiary of Viewbix upon closing. The agreement includes significant contingent consideration ("Earn-Out Securities") totaling up to 12,702,847 additional shares or warrants, issuable only after the 12-month anniversary of the Closing Date if specific milestones are met:
- Patent Milestone: Up to 1,975,998 shares for submitting 5 patent applications across 3 quantum sub-fields within 18 months.
- Portfolio Exit Milestone: Up to 3,436,519 shares for a listing, public offering, or M&A of a Portfolio Company at a pre-money valuation of at least $20 million within 24 months.
- Valuation/Capital Raise Milestone: Up to 7,290,330 shares upon a capital raise or M&A transaction at a pre-money valuation of at least $250 million within 48 months.
Conditions and Restrictions
- Closing Timeline: Expected within 90 calendar days of the Effective Date.
- Conditions Precedent: Final due diligence, regulatory approvals, stockholder approval (Nasdaq rules), and execution by shareholders holding at least 85% of Quantum's capital.
- Lock-Up: Viewbix Exchange Shares and shares from exercised warrants are subject to a 12-month lock-up post-closing.
- Escrow: Shares issued at closing will be held in escrow for 30 days pending a tax ruling from the Israeli Tax Authority.
Outlook, Risks, and Contingencies
Forward-Looking Statements: The completion of the acquisition is not guaranteed and is subject to customary closing conditions, including regulatory approvals and stockholder votes. The company explicitly states that forward-looking statements are based on present intent and may not occur.
Risks:
- Failure to obtain necessary regulatory or stockholder approvals.
- Failure to meet the 85% shareholder execution threshold for Quantum.
- Significant dilution to existing shareholders due to the issuance of up to 40% of current capital stock plus potential earn-outs.
- Tax contingencies requiring escrow of shares.
Investor Verification Checklist
- Verify the exact number of Viewbix shares outstanding as of December 15, 2025, to calculate the precise dilution impact of the 2,666,000 exchange shares.
- Confirm the status of the 85% shareholder execution requirement for Quantum X Labs Ltd.
- Review the full text of the Securities Exchange Agreement (Exhibit 10.1) for specific representations and warranties.
- Monitor the timeline for the 30-day escrow period and the outcome of the Israeli Tax Authority ruling.
- Assess the feasibility of the earn-out milestones, particularly the $250 million valuation target within 48 months.